1368008

3,3′,5-三碘代-L-甲状腺原氨酸

United States Pharmacopeia (USP) Reference Standard

• 同義詞: O-(4-羟基-3-碘苯基)-3,5-二碘代-L-酪氨酸, T₃, 碘噻罗宁
• 經驗公式（希爾表示法）: C₁₅H₁₂I₃NO₄
• CAS號碼: 6893-02-3
• 分子量：: 650.97
• Beilstein: 2710227
• MDL號碼: MFCD00002593
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329750059
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: liothyronine
• 製造商／商標名: USP
• mp: 234-238 °C (lit.)
• 應用: pharmaceutical (small molecule)
• 形式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O
• InChI: 1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1
• InChI 密鑰: AUYYCJSJGJYCDS-LBPRGKRZSA-N
• 基因資訊: human ... THRA(7067) , THRB(7068)

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Liothyronine USP reference standard for use in specified quality tests and assays.

Also used to prepare standard, standard stock, Liothyronine stock, and resolution solutions for assay, and identification test according to given below monographs of the United States Pharmacopeia (USP):

• Thyroid[1]
• Levothyroxine Sodium Tablets[2]
• Liothyronine Sodium Tablets[3]

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08
• 訊號詞: Danger
• 危險聲明: H372
• 防範說明: P260 - P264 - P270 - P314 - P501
• 危險分類: STOT RE 1
• 標靶器官: Thyroid,Cardio-vascular system,Kidney
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable